Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Abstract Background The efficacy of neoadjuvant chemo-immunotherapy (NAT) in esophageal squamous cell carcinoma (ESCC) is challenged by the intricate interplay within the tumor microenvironment (TME). Unveiling the immune landscape of ESCC in the context of NAT could shed light on heterogeneity and...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-04-01
|
| Seri Bilgileri: | Genome Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13073-024-01320-9 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
